Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-21 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 5,000 | $1.477 | $7,385 | 35,201 (Direct) | View |
| 2026-07-22 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | Dempsey Robert John CHIEF EXECUTIVE OFFICER | 15,000 | $1.539 | $23,085 | 15,000 (Direct) | View |
| 2026-07-21 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | JACOB GARY S CHIEF DEVELOPMENT OFFICER | 3,500 | $1.4 | $4,900 | 112,420 (Direct) | View |
| 2026-07-21 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Director 10% Owner | 22,500 | $1.45 | $32,625 | 10,873,916 (Indirect) | View |
| 2026-07-20 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Director 10% Owner | 25,000 | $1.4 | $35,000 | 10,851,416 (Indirect) | View |
| 2026-07-21 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | Mantelli Flavio CHIEF MEDICAL OFFICER | 20,000 | $1.4 | $28,000 | 20,000 (Direct) | View |
| 2026-07-27 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | Patil Rajkumar V. Chief Scientific Officer | 3,363 | $1.49 | $5,011 | 20,030 (Direct) | View |
| 2023-09-15 Purchase | 2023-09-28 06:15 am | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 16,670 | $1.5 | $25,005 | 16,670 (Direct) | View |
| 2022-05-19 Purchase | 2022-05-20 10:35 am | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman | 5,800,000 | $0.076 | $440,800 | 548,981,215 (Indirect) | View |
| 2022-05-17 Purchase | 2022-05-18 11:37 am | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Non-Executive Chairman 10% Owner | 1,625,000 | $0.0595 | $96,688 | 544,806,215 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-27 Option Award | 2026-07-29 4:45 pm | N/A N/A | OKYO Pharma Ltd | OKYO | Patil Rajkumar V. Chief Scientific Officer | 3,363 | $1.49 | 20,030 (Direct) | View |
Ownership | 2026-07-29 4:30 pm | N/A N/A | OKYO Pharma Ltd | OKYO | Patil Rajkumar V. Chief Scientific Officer | 0 | $0 | 591,667 (Direct) | View |
| 2026-07-22 Option Award | 2026-07-23 4:20 pm | N/A N/A | OKYO Pharma Ltd | OKYO | Dempsey Robert John CHIEF EXECUTIVE OFFICER | 15,000 | $1.539 | 15,000 (Direct) | View |
| 2026-07-21 Option Award | 2026-07-23 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Director 10% Owner | 22,500 | $1.45 | 10,873,916 (Indirect) | View |
| 2026-07-21 Option Award | 2026-07-23 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | JACOB GARY S CHIEF DEVELOPMENT OFFICER | 3,500 | $1.4 | 112,420 (Direct) | View |
| 2026-07-21 Option Award | 2026-07-23 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 5,000 | $1.477 | 35,201 (Direct) | View |
| 2026-07-21 Option Award | 2026-07-22 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | Mantelli Flavio CHIEF MEDICAL OFFICER | 20,000 | $1.4 | 20,000 (Direct) | View |
| 2026-07-20 Option Award | 2026-07-21 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Director 10% Owner | 25,000 | $1.4 | 10,851,416 (Indirect) | View |
Ownership | 2026-06-17 4:15 pm | 2027-02-10 2036-02-10 | OKYO Pharma Ltd | OKYO | Mantelli Flavio CHIEF MEDICAL OFFICER | 0 | $0 | 750,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 5:00 pm | 2027-06-08 2036-06-08 | OKYO Pharma Ltd | OKYO | Denoyer Bernard Director | 3,500 | $1.85 | 35,190 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 5:00 pm | 2027-06-08 2036-06-08 | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 6,500 | $1.85 | 138,394 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 5:00 pm | 2027-06-08 2036-06-08 | OKYO Pharma Ltd | OKYO | Simon Willy Jules Director | 6,500 | $1.85 | 135,502 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 5:00 pm | 2027-06-08 2036-06-08 | OKYO Pharma Ltd | OKYO | Shah Keeren Rameshchandra Chief Financial Officer | 40,000 | $1.85 | 544,819 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:30 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Director 10% Owner | 300,000 | $1.72 | 10,826,416 (Indirect) | View |
Ownership | 2026-06-02 7:28 pm | 2024-03-14 2033-03-14 | OKYO Pharma Ltd | OKYO | Denoyer Bernard Director | 0 | $0 | 31,690 (Direct) | View |
Ownership | 2026-06-01 6:48 pm | N/A N/A | OKYO Pharma Ltd | OKYO | Simon Willy Jules Director | 0 | $0 | 144,385 (Direct) | View |
Ownership | 2026-06-01 6:44 pm | N/A N/A | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 0 | $0 | 162,095 (Direct) | View |
Ownership | 2026-05-22 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | Shah Keeren Rameshchandra CHIEF FINANCIAL OFFICER | 0 | $0 | 521,486 (Direct) | View |
Ownership | 2026-05-22 4:15 pm | 2027-01-02 2036-01-02 | OKYO Pharma Ltd | OKYO | Dempsey Robert John CHIEF EXECUTIVE OFFICER | 0 | $0 | 1,600,000 (Direct) | View |
Ownership | 2026-03-18 8:37 pm | N/A N/A | OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Development Officer | 0 | $0 | 1,108,829 (Direct) | View |
Ownership | 2026-03-18 8:35 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Director 10% Owner | 0 | $0 | 10,526,416 (Direct) | View |
| 2023-10-23 Other | 2023-10-31 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman | 569,539 | $1.5 | 9,747,442 (Indirect) | View |
Ownership | 2022-05-16 5:53 pm | N/A 2028-08-19 | OKYO Pharma Ltd | OKYO | Shah Keeren Chief Financial Officer | 0 | $0 | 950,000 (Direct) | View |
Ownership | 2022-05-16 5:52 pm | N/A 2025-06-07 | OKYO Pharma Ltd | OKYO | Simon Willy Jules Director | 0 | $0 | 2,000,000 (Direct) | View |
Ownership | 2022-05-16 5:47 pm | N/A 2028-08-19 | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 0 | $0 | 1,450,000 (Direct) | View |
Ownership | 2022-05-16 5:44 pm | N/A 2029-01-06 | OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Executive Officer | 0 | $0 | 53,000,000 (Direct) | View |
Ownership | 2022-05-16 5:41 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman 10% Owner | 0 | $0 | 543,181,215 (Indirect) | View |